This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated

NCT03165240 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathies

Interventions

DRUG: BI 690517
DRUG: Eplerenone
DRUG: Placebo

Sponsor

Boehringer Ingelheim